Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06640985 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EDX110 - Efficacy and Safety in the Management of Hard-to-heal Wounds

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Active, Not Recruitingv3 Show 4 more changesShow less
    • Enrollment target: estimated 80 to confirmed 43
    • Primary and study completion dates: Nov 2025 to Feb 2026
    • Start date changed from estimate of Nov 2024 to Dec 4, 2024
    • Study site revised
  2. Secondary endpoints: details revised at 2 of 3 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ConvaTec Inc.
11 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Post-market study to determine the efficacy of EDX110 dressing system in hard-to-heal wounds.
Trial Details
NCT Number NCT06640985
Lead Sponsor ConvaTec Inc.
Conditions
(from sponsor)		 Wound Healing, Diabetic Foot, Foot Ulcer, Diabetic, Venous Ulcer
Related terms Diabetic Foot, Varicose Ulcer
Enrollment 43 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov